Rezultaty - Hervé Dombret

Redukuj rezultaty
  1. 1
    Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia---results of the prospective multicenter LALA-94 trial

    Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia---results of the prospective multicenter LALA-94 trial od Hervé Dombret

    Wydane 2002
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    An update of current treatments for adult acute myeloid leukemia

    An update of current treatments for adult acute myeloid leukemia od Hervé Dombret, Claude Gardin

    Wydane 2015
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion

    Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion od Étienne Lengliné, Kheïra Beldjord, Hervé Dombret, Jean Soulier, Nicolas Boissel, Emmanuelle Clappier

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Carta
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up od D. Hoelzer, Renato Bassan, Hervé Dombret, Adele K. Fielding, Josep‐María Ribera, Christian Buske

    Wydane 2016
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia

    Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia od Delphine Réa, Tristan Mirault, Thomas Cluzeau, Jean‐François Gautier, François Guilhot, Hervé Dombret, Emmanuel Messas

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

    All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments] od L Degos, Hervé Dombret, Christine Chomienne, M‐T. Daniel, JM Micléa, Claude Chastang, Sylvie Castaigné, Pierre Fenaux

    Wydane 1995
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    Severe Peripheral Arterial Disease During Nilotinib Therapy

    Severe Peripheral Arterial Disease During Nilotinib Therapy od Philipp le Coutre, Delphine Réa, Elisabetta Abruzzese, Hervé Dombret, Malgorzata Monika Trawinska, Susanne Herndlhofer, Bernd Dörken, Peter Valent

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Carta
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse

    Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse od Zena Khaznadar, Guylaine Henry, Niclas Setterblad, Sophie Agaugué, Emmanuel Raffoux, Nicolas Boissel, Hervé Dombret, Antoine Toubert, Nicolas Dulphy

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

    All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot s... od Pierre Fenaux, Sylvie Castaigné, Hervé Dombret, E Archimbaud, M Duarte, Pierre Morel, Thierry Lamy, H Tilly, A. Guerci, F. Maloisel

    Wydane 1992
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia

    Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia od Aline Renneville, Nicolas Boissel, Virginie Zurawski, Laura Llopis, Valéria Biggio, Olivier Nibourel, N Philippe, Xavier Thomas, Hervé Dombret, Claude Preudhomme

    Wydane 2009
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  11. 11
    HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)

    HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL) od Jean Soulier, Emmanuelle Clappier, Jean‐Michel Cayuela, Armelle Régnault, Marina García-Peydró, Hervé Dombret, André Baruchel, Marı́a L. Toribio, François Sigaux

    Wydane 2005
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  12. 12
    Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

    Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab od Max S. Topp, Zachary Zimmerman, Paul Cannell, Hervé Dombret, Johan Maertens, Anthony S. Stein, Janet Franklin, Qui Tran, Ze Cong, Andre C. Schuh

    Wydane 2018
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  13. 13
    Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia

    Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia od Jorge E. Cortés, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  14. 14
    Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia

    Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia od Hervé Dombret, Max S. Topp, Andre C. Schuh, Andrew H. Wei, Simon Durrant, Christopher Larry Bacon, Qui Tran, Zachary Zimmerman, Hagop M. Kantarjian

    Wydane 2019
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  15. 15
    Dexamethasone in patients with acute lung injury from acute monocytic leukaemia

    Dexamethasone in patients with acute lung injury from acute monocytic leukaemia od Élie Azoulay, Emmanuel Canet, Emmanuel Raffoux, Étienne Lengliné, Virginie Lemiale, François Vincent, Adrienne de Labarthe, Amélie Seguin, Nicolas Boissel, Hervé Dombret, Benoı̂t Schlemmer

    Wydane 2011
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  16. 16
    Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

    Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial od Christophe Willekens, Odile Blanchet, Aline Renneville, Pascale Cornillet‐Lefèbvre, Cécile Pautas, Romain Guièze, Norbert Ifrah, Hervé Dombret, Éric Jourdan, Claude Preudhomme, Nicolas Boissel

    Wydane 2015
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  17. 17
    Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia

    Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia... od Alessandro Rambaldi, Josep‐María Ribera, Hagop M. Kantarjian, Hervé Dombret, Oliver G. Ottmann, Anthony S. Stein, Catherine Tuglus, Xiaoyue Zhao, Christopher Kim, Giovanni Martinelli

    Wydane 2019
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  18. 18
    A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

    A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission od Norbert Vey, Jean Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prébet, Aude Charbonnier, Anne Etienne, Pascale André, François Romagné, Don Benson, Hervé Dombret, Daniel Olive

    Wydane 2012
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  19. 19
    A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

    A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia od Hervé Dombret, Claude Chastang, Pierre Fenaux, Josy Reiffers, Dominique Bordessoule, Réda Bouabdallah, Franco Mandelli, Augustin Ferrant, G Auzanneau, Hervé Tilly, Antoine Yver, Laurent Degos

    Wydane 1995
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  20. 20
    Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs

    Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs od Julie Bergeron, Emmanuelle Clappier, Isabelle Radford, Agnès Buzyn, Corinne Millien, Gwendoline Soler, Paola Ballerini, Xavier Thomas, Jean Soulier, Hervé Dombret, Elizabeth Macintyre, Vahid Asnafi

    Wydane 2007
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: